Utah Medical Products Inc (UTMD) — SEC Filings
Utah Medical Products Inc (UTMD) — 32 SEC filings. Latest: 8-K (May 4, 2026). Includes 13 8-K, 7 SC 13G/A, 6 10-Q.
View Utah Medical Products Inc on SEC EDGAR
Overview
Utah Medical Products Inc (UTMD) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-Q filed on Nov 14, 2025: UTAH MEDICAL PRODUCTS INC (UTMD) reported a significant decline in financial performance for the three and nine months ended September 30, 2025. Net sales decreased by 1.9% to $9,812 thousand in Q3 2025 from $10,005 thousand in Q3 2024, and by 7.2% to $29,475 thousand for the nine months from $31,74
Sentiment Summary
Across 32 filings, the sentiment breakdown is: 1 bullish, 1 bearish, 29 neutral, 1 mixed. The dominant filing sentiment for Utah Medical Products Inc is neutral.
Filing Type Overview
Utah Medical Products Inc (UTMD) has filed 13 8-K, 6 10-Q, 2 DEF 14A, 2 10-K, 7 SC 13G/A, 1 SC 13G, 1 DEFA14A with the SEC between Jan 2024 to May 2026.
Filings by Year
Recent SEC Filings (32)
Risk Profile
Risk Assessment: Of UTMD's 22 recent filings, 1 were flagged as high-risk, 5 as medium-risk, and 16 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $9,812,000 |
| Net Income | $2,631,000 |
| EPS | $0.82 |
| Debt-to-Equity | 0.03 |
| Cash Position | $84,267,000 |
| Operating Margin | 26.6% |
| Total Assets | $121,975,000 |
| Total Debt | $3,723,000 |
Key Executives
- Abigail P. Johnson
Industry Context
UTMD operates in the specialty medical device market, characterized by innovation and regulatory oversight. The company's performance is sensitive to global supply chain dynamics and the purchasing decisions of international distributors, as highlighted by recent order cancellations.
Top Tags
financial-reporting (5) · 10-Q (4) · financials (3) · corporate-governance (3) · 8-k (3) · SEC Filing (3) · Financials (3) · institutional-ownership (3) · amendment (3) · medical-devices (3)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Net Sales (Q3 2025) | $9.81M | Decreased by 1.9% from $10.01M in Q3 2024 |
| Net Income (Q3 2025) | $2.63M | Decreased by 26.2% from $3.56M in Q3 2024 |
| Diluted EPS (Q3 2025) | $0.82 | Decreased by 19.9% from $1.025 in Q3 2024 |
| Lost Revenues (Q3 2025) | $581K | Due to foreign distributor order cancellations |
| Bad Debt Expense (Q3 2025) | $395K | Additional reserve for China distributor |
| Gross Profit Margin (Q3 2025) | 57.1% | Reduced from 58.0% in Q3 2024 due to lower sales and absorption |
| Operating Income Margin (Q3 2025) | 26.6% | Declined from 33.4% in Q3 2024 |
| Shares Outstanding | 3,203,672 | As of November 10, 2025 |
| Common Stock Purchased and Retired (9M 2025) | $7.36M | Reduced from $13.26M in 9M 2024 |
| Cash & Investments (Sept 30, 2025) | $84.27M | Increased from $82.98M at Dec 31, 2024 |
| Revenue | $24.8M | Decreased from $25.5M in H1 2024 to $24.8M in H1 2025, a 2.7% decline. |
| Net Income | $4.5M | Decreased from $5.1M in H1 2024 to $4.5M in H1 2025. |
| Revenue Decline | 2.7% | Percentage decrease in revenue for the six months ended June 30, 2025, compared to the prior year. |
| Domestic Revenue | $18.6M | Revenue from US operations for the first half of 2025. |
| International Revenue | $6.2M | Revenue from outside US operations for the first half of 2025. |
Forward-Looking Statements
- {"claim":"FMR LLC will maintain a significant ownership stake in Utah Medical Products Inc. for the foreseeable future.","entity":"FMR LLC","targetDate":"2025-02-09","confidence":"high"}
Frequently Asked Questions
What are the latest SEC filings for Utah Medical Products Inc (UTMD)?
Utah Medical Products Inc has 32 recent SEC filings from Jan 2024 to May 2026, including 13 8-K, 7 SC 13G/A, 6 10-Q. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of UTMD filings?
Across 32 filings, the sentiment breakdown is: 1 bullish, 1 bearish, 29 neutral, 1 mixed. The dominant sentiment is neutral.
Where can I find Utah Medical Products Inc SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Utah Medical Products Inc (UTMD) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Utah Medical Products Inc?
Key financial highlights from Utah Medical Products Inc's most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for UTMD?
The investment thesis for UTMD includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Utah Medical Products Inc?
Key executives identified across Utah Medical Products Inc's filings include Abigail P. Johnson.
What are the main risk factors for Utah Medical Products Inc stock?
Of UTMD's 22 assessed filings, 1 were flagged high-risk, 5 medium-risk, and 16 low-risk.
What are recent predictions and forward guidance from Utah Medical Products Inc?
Recent forward-looking statements from Utah Medical Products Inc include guidance on {"claim":"FMR LLC will maintain a significant ownership stake in Utah Medical Products Inc. for the foreseeable future.".